Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Perrigo

www.perrigo.com

Treasury Building
Lower Grand Canal Street
Dublin 2
Ireland

+353 1 709 4000

Activities

Ingredients | Pharmaceutical | Dietary supplements | Active Nutrition | Food

Related Companies

  • Lonza
  • Icrom SRL
  • Piramal Pharma Solutions
  • JRS Pharma
  • Rousselot
  • Marchesini Group
  • Rentschler Biopharma SE
  • Indena
  • Quotient Sciences
  • 3P innovation
  • C-squared Pharma
  • Actylis – The Partner of Choice
  • Admix

Related Content

Catalent client gets FDA approval for generic bronchodilator
Catalent client gets FDA approval for generic bronchodilator
Hikma enters into licensing partnership with Perrigo in MENA
Hikma enters into licensing partnership with Perrigo in MENA
Mylan fails in US$26bn hostile takeover bid for Perrigo
Mylan fails in US$26bn hostile takeover bid for Perrigo
Operational cost savings for Perrigo UK
Operational cost savings for Perrigo UK
Perrigo to acquire OTC brands from GSK
Perrigo to acquire OTC brands from GSK
Perrigo acquires Patheon's Mexican operations for US$34m
Perrigo acquires Patheon's Mexican operations for US$34m
Perrigo Board unanimously rejects unsolicited US$29bn bid from Mylan
Perrigo Board unanimously rejects unsolicited US$29bn bid from Mylan
Mylan offers to buy Perrigo for US$29bn
Mylan offers to buy Perrigo for US$29bn
Perrigo to purchase Omega Pharma for €3.6bn
Perrigo to purchase Omega Pharma for €3.6bn
Perrigo recalls OTC infant suspension liquid owing to potential packaging defects
Perrigo recalls OTC infant suspension liquid owing to potential packaging defects
Perrigo to buy Elan for US$8.6bn
Perrigo to buy Elan for US$8.6bn
Elan buys AOP Orphan and takes stake in Newbridge Pharmaceuticals
Elan buys AOP Orphan and takes stake in Newbridge Pharmaceuticals
Royalty Pharma offers to buy Elan for US$6.5bn
Royalty Pharma offers to buy Elan for US$6.5bn
CBPE Capital sells Rosemont Pharmaceuticals to Perrigo
CBPE Capital sells Rosemont Pharmaceuticals to Perrigo
UCD and Elan to establish Business of Biotechnology Chair
UCD and Elan to establish Business of Biotechnology Chair
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company